Home
>
US Stocks
>
Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp
ADPT

Adaptive Biotechnologies Corp

$31.985.08%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
32.8
Today Low/High
31.83 / 32.99
52 Week Low/High
$29.83 / $71.25
P/E ratio
-25.1473
Market Cap
$4.31B

Company Details

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Adaptive Biotechnologies believes the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Its proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have three commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune conditions and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.
Organisation
Adaptive Biotechnologies Corp
Headquaters
Seattle, Washington, US
Employees
622
Industry
Commercial Services
CEO
Chad Robins

Discover more

Frequently Asked Questions

What is Adaptive Biotechnologies Corp share price today

Can Indians buy Adaptive Biotechnologies Corp shares?

How can I buy Adaptive Biotechnologies Corp shares from India?

Can Fractional shares of Adaptive Biotechnologies Corp be purchased?

What are the documents required to start investing in Adaptive Biotechnologies Corp stocks?

We are a SEBI registered investement advisor